The MARVEL project
“Evolving reversible immunocapture by membrane sensing peptides: towards scalable extracellular vesicles isolation” – brings innovation to healthcare and especially to its diagnostic and therapeutic tools.
Find out more
news from EVengers
Extracellular Vesicles (EVs) as innovative drugs: large scale GMP manufacturing
3.12.2021
Cardiac progenitor cells secrete exosomes, nanosized extracellular vesicles (EV) with anti-apoptotic and pro-angiogenic biological activities. ...
Save the date – MARVEL workshop
3.12.2021
SAVE THE DATE 🗓️ – come to share📣 or to know more📔! We are bringing ...
MARVEL Project – ONE YEAR ANNIVERSARY
15.11.2021
One year after the start of the project and we finally had our first in-person ...
MassiveEVs Workshop – more results on large scale EV production
29.10.2021
On 28 – 29 October 2021, two of our partners participated in the “massivEVs” workshop ...
Elaboration of modified membranes for extracellular vesicles isolation and purification by the tangential flow filtration
26.10.2021
MARVEL project partner, CNR-ITM, is currently working on the elaboration of a highly selective membrane ...
The 2nd EVITA symposium – we won!
22.9.2021
Our poster won the first prize among 76 competitors at the 2nd EVITA symposium which ...
MARVEL project M6 meeting
14.5.2021
The intensive M6 meeting of the MARVEL (Evolving reversible immunocapture by membrane sensing peptides: towards ...
EuroNanoForum 2021: MARVEL project took part in!
6.5.2021
MARVEL project has been presented at the largest European networking conference, EuroNanoForum 2021, focused on ...
MARVEL project has been presented at European Researchers’ Night
24.11.2020
On November 27th MARVEL project has been presented at European Researchers’ Night which held this ...
MARVEL project has kicked-off!
6.11.2020
On November 5th – 6th, 2020 MARVEL project was officially kicked-off via online conferencing service where all ...